Fish Post-Grant Radio: A series of podcasts dedicated to the discussion of developments in post-grant proceedings before the Patent Trial and Appeal Board and related practice tips.
Our host, Stuart Nelson, an attorney in our Twin Cities office, talks with practitioners and thought leaders across the country to discuss a wide range of post-grant topics. Be sure to visit fishpostgrant.com to listen to all of our past episodes and to subscribe to this podcast! To listen on-the-go, please download our app. You can also follow us on Twitter @fishpostgrant or subscribe by choosing one of the methods below.
This episode of Fish Post-Grant Radio features Fish Principals Karl Renner & Tom Rozylowicz. In this interview, they discuss the shift in patent post-grant practice after the AIA, and how they initially became involved in the newly formed PTAB Bar Association. They also talk about the PTAB Bar Association Inaugural Conference that took place in March 2017 in Washington, D.C., and how the PTAB Bar Association is helping to open up dialogue and propel the practice forward. Karl and Tom also cover what they see in the future for post-grant practitioners.
Host Stuart Nelson interviews Mike Jay, a partner with Boies, Schiller, and Flexner, on how litigators view IPR proceedings and the challenges and benefits of working with post-grant counsel from a different firm.
This episode of Fish Post-Grant Radio features Tom Rozylowicz, Fish Principal and a member of our Post-Grant Practice, who talks about the Patent Trial and Appeal Board’s recent “Motion to Amend” Study.
This episode of Fish Post-Grant Radio features Kevin Jakel, Founder and CEO of UnifiedPatents, who talks about his experience with post-grant proceedings and IPRs. Kevin has more than 12 years of intellectual property experience, and most recently served as Intuit’s Head of IP Litigation.
This episode of Fish Post-Grant Radio features Dorothy Whelan, Principal and Co-Chair of Fish’s Post-Grant practice group. As the co-chair of one of the most active post-grant practices in the United States, Dorothy discusses emerging trends in challenging and defending life sciences, pharmaceutical, and biosimilar patents at the USPTO. She also covers trends in inter partes review and how litigators are using these proceedings to develop successful new strategies.